JH
At a glance
Background
Career
TC
Washington, DC · current
Government experience
Staff Director
Sen. Veterans Affairs Committee
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
0
past 12 months
Filings
0
last filed Apr 2025
Specific issues
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169).
Issues related to Orphan drug coverage under Medicare.
Issues related to PBM reform.
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act (118th Congress).
Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (118th Congress).
Issues related to the 340b program - Public Health Service Act (P.L. 78-410); Issues related to PBM reform.
Clients
No client work disclosed in the past 12 months.
Past clients12
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Older filings20
GRAIL, LLC
AMGEN, INC.
ELI LILLY AND COMPANY
TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)
TIBER CREEK GROUP (ON BEHALF OF MERCK & CO INC)
GENENTECH, INC.
TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)
FRESENIUS MEDICAL CARE NORTH AMERICA
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
NOVARTIS
TIBER CREEK GROUP (ON BEHALF OF EMD SERONO, INC.)
GENENTECH, INC.
TIBER CREEK GROUP (ON BEHALF OF MERCK & CO INC)
TIBER CREEK GROUP (ON BEHALF OF BRISTOL MYERS SQUIBB)
TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)
GRAIL, LLC
TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)
NOVARTIS
AMGEN, INC.
FRESENIUS MEDICAL CARE NORTH AMERICA